Early study of ART002g1 for inherited high cholesterol
Part of Heart & circulation, Hormones & metabolism clinical trials.
This trial tests a new injection called ART002g1 for people with a genetic condition that causes very high cholesterol. It aims to see if the drug is safe and can help lower cholesterol levels.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 70 years old.
- You weigh between 99 and 198 pounds (45 to 90 kg).
- You have a confirmed diagnosis of heterozygous familial hypercholesterolemia (HeFH), meaning you have a specific gene mutation or meet certain clinical criteria.
- You do not have other types of high cholesterol conditions like homozygous FH or mixed FH.
- You have not had a heart attack, stroke, or certain heart procedures in the past 6 months.
- You do not have active hepatitis B, C, or HIV.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study checks how common fatty liver disease is in people with a genetic form of high cholesterol. It may help researchers understand the link between these two conditions.
This trial tests a new gene therapy called YOLT-101 for people with familial hypercholesterolemia, a genetic condition that causes very high cholesterol. The treatment aims to lower cholesterol levels and reduce heart risks.
This trial tests a one-time gene therapy (NGGT006) to treat a severe form of inherited high cholesterol that doesn't respond well to standard medications. It aims to lower cholesterol and reduce the risk of heart disease.
This trial tests an experimental medication called QLC7401 for people with a genetic condition that causes very high cholesterol. It aims to lower cholesterol levels safely and may be an option for those who need better control.
This study tests a new injectable medication (SYH2070) designed to lower cholesterol in people with homozygous familial hypercholesterolemia—a genetic condition that causes extremely high cholesterol levels despite treatment. The goal is to see if this drug safely reduces cholesterol better than current options.
This trial tests a new gene therapy (NGGT006) for people with a genetic form of high cholesterol that doesn't respond to standard treatments. It aims to lower cholesterol levels that remain high despite maximum medication.
Hear when a new Heterozygous Familial Hypercholesterolemia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.